In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...